Immediate Impact
17 from Science/Nature 55 standout
Citing Papers
Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation
2025 Standout
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Works of Harry Raftopoulos being referenced
Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non–small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study
2018
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
2016 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Harry Raftopoulos | 1518 | 1085 | 564 | 40 | 2.3k | |
| Steven Powell | 2531 | 1556 | 551 | 90 | 3.5k | |
| Yutaka Horiguchi | 705 | 743 | 769 | 67 | 2.3k | |
| S P Balcerzak | 1491 | 1285 | 275 | 63 | 2.8k | |
| Hirohisa Yoshizawa | 1710 | 1194 | 551 | 84 | 3.4k | |
| Michel Bihl | 897 | 897 | 432 | 58 | 2.5k | |
| Eva Lieto | 1685 | 1114 | 840 | 67 | 3.0k | |
| J.H.J.M. van Krieken | 1511 | 1312 | 1005 | 34 | 3.4k | |
| Luigi Manzione | 2389 | 1272 | 619 | 88 | 3.4k | |
| Michel Marty | 1806 | 472 | 564 | 47 | 3.0k | |
| Simon Tchekmedyian | 2174 | 1240 | 410 | 28 | 3.2k |
All Works
Loading papers...